Genmab — Marts 2025
-
acasunlimab Trial design - 128TiP - ABBIL1TY NSCLC-06: A global, randomized, open-label, phase III trial of acasunlimab in combination with pembrolizumab (Pembro) vs docetaxel in checkpoint inhibitor (CPI)-experienced patients with PD-L1+ metastatic non-small cell lung cancer (mNSCLC) https://cslide.ctimeetingtech.com/coasis_21204/attendee/confcal/presentation/list?q=acasunlimab+#presentation-abstract-356715098915
-
presentation: Congress:
SGO 2025
Product:
Rinatabart Sesutecan https://www.genmabmedicalaffairs.com/congress?filv1=22 -
Ofatumumab for the treatment of COVID-19-associated autoimmune encephalitis: A case report https://www.sciencedirect.com/science/article/abs/pii/S0165572825000700
-
-
RYBREVANT
(amivantamab-vmjw) plus LAZCLUZE
(lazertinib) significantly outperforms standard of care in first-line EGFR-mutated lung cancer with compelling new data at ELCC 2025 https://www.jnj.com/media-center/press-releases/rybrevant-amivantamab-vmjw-plus-lazcluze-lazertinib-significantly-outperforms-standard-of-care-in-first-line-egfr-mutated-lung-cancer-with-compelling-new-data-at-elcc-2025 -
Ved vi noget om status på tilbagekøbsprogrammet?
-
Solsen tror ik det er det rigtige sammenlignings grundlng. Det er 2L. Har prøvet at finde data på FLAURA2 men der er ik OS på nuværende tidspunkt. Men den kombi ser generelt stærk ud , men med chemo kommer der også AEs på niveau eller mere end Ami+Laz.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind